Skip to content

IDEXX LABORATORIES INC /DE

IDXX

CIK 0000874716

← back to feed
Revenue (TTM)
$4.35B
+10.4% YoY Q1 Apr 2026
Net Income (TTM)
$1.09B
+19.3% YoY Q1 Apr 2026
EPS Diluted (TTM)
$13.46
+22.6% YoY Q1 Apr 2026
Gross Margin
62.6%
Q1 Apr 2026
Operating Margin
32.3%
Q1 Apr 2026
Net Margin
25.0%
Q1 Apr 2026
Free Cash Flow (TTM)
$754.91M
Q1 Apr 2026
Cash
$200.53M
Q1 Apr 2026
Total Debt
$449.85M
Q1 Apr 2026
Shares Outstanding
78.88M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings